1972
DOI: 10.1016/0022-3468(72)90274-6
|View full text |Cite
|
Sign up to set email alerts
|

A new theory of biliary atresia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
8
0
1

Year Published

1976
1976
2014
2014

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 25 publications
(9 citation statements)
references
References 12 publications
0
8
0
1
Order By: Relevance
“…A associação entre a AVBEH e as anomalias da veia porta e artéria hepática sugere que uma lesão isquêmica intraútero pode influenciar o desenvolvimento das vias biliares, podendo ter algum papel na patogênese da atresia 58,59 .…”
Section: Diminuição Do Suprimento Arterial Hepáticounclassified
“…A associação entre a AVBEH e as anomalias da veia porta e artéria hepática sugere que uma lesão isquêmica intraútero pode influenciar o desenvolvimento das vias biliares, podendo ter algum papel na patogênese da atresia 58,59 .…”
Section: Diminuição Do Suprimento Arterial Hepáticounclassified
“…We administered PGE 1 to rats just after birth because PGE 1 has a dilatory effect on the ductus venosus and ductus arteriosus [19][20][21] and because the blood flow to the BD would be decreased due to the decreased patency of these vessels [22]. Of note, the PG-induced BDPF was not remarkable, as described before.…”
Section: Discussionmentioning
confidence: 89%
“…In addition, the administration of prostaglandin (PG) E, a vasodilator, leads to the development of a persistent ductus venosus and ductus arteriosus in neonatal animals [19][20][21]. Theoretically, the persistence of the ductus arteriosus induces a decrease in the blood flow in the hepatic artery [22]. Therefore, it is hypothesized that cholestasis in neonatal small animals would be induced by hypoxia/ischemia in the BDs and/or liver tissue, which could be achieved by PG treatment and/or ligation of the hepatic artery.…”
Section: Introductionmentioning
confidence: 99%
“…There are many predisposing factors to the development of inspissated bile, sludge, or cholelithiasis in neonates 31,32 Ceftriaxone pseudolithiasis, composed of precipitated ceftriaxone, is reported to occur in 29.5% to 45.7% of children treated with ceftriaxone 33 . The pseudolithiasis occurs after 4 to 22 days (mean, 9 days) of ceftriaxone therapy and resolves after 2 to 63 days (mean, 15 days) from the end of treatment 34 .Cefotaxime, was previously reported to be associated with pseudolithiasis in 2 of 34 infants (6%) who had cholelithiasis 31 .…”
Section: Inspissated Bile Syndromementioning
confidence: 97%